Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Berghoff

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
British Journal of Pharmacology|October 5, 2024
Anti-inflammatory and remyelinating effects of fexagratinib in experimental multiple sclerosisFynn Gurski, Kian Shirvanchi, Vinothkumar Rajendran, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|October 10, 2013
Evidence-based patient information programme in early multiple sclerosis: a randomised controlled trialSascha Köpke, Simone Kern, Tjalf Ziemssen, et al.
Neurogenetics|July 25, 2018
The polynucleotide kinase 3'-phosphatase gene (PNKP) is involved in Charcot-Marie-Tooth disease (CMT2B2) previously related to MED25Alejandro Leal, Sixto Bogantes-Ledezma, Arif B Ekici, et al.
Clinical Imaging|July 16, 2016
Factors influencing intracranial vessel densities on unenhanced computed tomography: differences between hemispheresAstrid E Grams, Rafael Rehwald, Charlotte Schmittnägel, et al.
Neurogenetics|July 8, 2003
Charcot-Marie-Tooth disease: a novel Tyr145Ser mutation in the myelin protein zero (MPZ, P0) gene causes different phenotypes in homozygous and heterozygous carriers within one familyAlejandro Leal, Corinna Berghoff, Martin Berghoff, et al.
British Journal of Pharmacology|July 4, 2023
The small molecule fibroblast growth factor receptor inhibitor infigratinib exerts anti-inflammatory effects and remyelination in a model of multiple sclerosisRanjithkumar Rajendran, Vinothkumar Rajendran, Gregor Böttiger, et al.
Neurogenetics|December 10, 2014
Identification of the variant Ala335Val of MED25 as responsible for CMT2B2: molecular data, functional studies of the SH3 recognition motif and correlation between wild-type MED25 and PMP22 RNA levels in CMT1A animal modelsAlejandro Leal, Kathrin Huehne, Finn Bauer, et al.
Neurogenetics|March 18, 2009
Identification of the variant Ala335Val of MED25 as responsible for CMT2B2: molecular data, functional studies of the SH3 recognition motif and correlation between wild-type MED25 and PMP22 RNA levels in CMT1A animal modelsAlejandro Leal, Kathrin Huehne, Finn Bauer, et al.
Journal of Neurology|March 22, 2022
Decline in the number of patients with meningitis in German hospitals during the COVID-19 pandemicStefanie Völk, Markus Pfirrmann, Uwe Koedel, et al.
Der Nervenarzt|July 23, 2021
[Multiple sclerosis treatment consensus group (MSTCG): position paper on disease-modifying treatment of multiple sclerosis 2021 (white paper)]Heinz Wiendl, Ralf Gold, Thomas Berger, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
British Journal of Pharmacology|October 5, 2024
Anti-inflammatory and remyelinating effects of fexagratinib in experimental multiple sclerosisFynn Gurski, Kian Shirvanchi, Vinothkumar Rajendran, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|October 10, 2013
Evidence-based patient information programme in early multiple sclerosis: a randomised controlled trialSascha Köpke, Simone Kern, Tjalf Ziemssen, et al.
Neurogenetics|July 25, 2018
The polynucleotide kinase 3'-phosphatase gene (PNKP) is involved in Charcot-Marie-Tooth disease (CMT2B2) previously related to MED25Alejandro Leal, Sixto Bogantes-Ledezma, Arif B Ekici, et al.
Clinical Imaging|July 16, 2016
Factors influencing intracranial vessel densities on unenhanced computed tomography: differences between hemispheresAstrid E Grams, Rafael Rehwald, Charlotte Schmittnägel, et al.
Neurogenetics|July 8, 2003
Charcot-Marie-Tooth disease: a novel Tyr145Ser mutation in the myelin protein zero (MPZ, P0) gene causes different phenotypes in homozygous and heterozygous carriers within one familyAlejandro Leal, Corinna Berghoff, Martin Berghoff, et al.
British Journal of Pharmacology|July 4, 2023
The small molecule fibroblast growth factor receptor inhibitor infigratinib exerts anti-inflammatory effects and remyelination in a model of multiple sclerosisRanjithkumar Rajendran, Vinothkumar Rajendran, Gregor Böttiger, et al.
Neurogenetics|December 10, 2014
Identification of the variant Ala335Val of MED25 as responsible for CMT2B2: molecular data, functional studies of the SH3 recognition motif and correlation between wild-type MED25 and PMP22 RNA levels in CMT1A animal modelsAlejandro Leal, Kathrin Huehne, Finn Bauer, et al.
Neurogenetics|March 18, 2009
Identification of the variant Ala335Val of MED25 as responsible for CMT2B2: molecular data, functional studies of the SH3 recognition motif and correlation between wild-type MED25 and PMP22 RNA levels in CMT1A animal modelsAlejandro Leal, Kathrin Huehne, Finn Bauer, et al.
Journal of Neurology|March 22, 2022
Decline in the number of patients with meningitis in German hospitals during the COVID-19 pandemicStefanie Völk, Markus Pfirrmann, Uwe Koedel, et al.
Der Nervenarzt|July 23, 2021
[Multiple sclerosis treatment consensus group (MSTCG): position paper on disease-modifying treatment of multiple sclerosis 2021 (white paper)]Heinz Wiendl, Ralf Gold, Thomas Berger, et al.
Pageof 5